Multiple Sclerosis Diagnostic Criteria Moving Ahead or Walking in Place?

被引：2

作者：

Cutter, Gary R. ^{[1
]}

Koch, Marcus W. ^{[2
,3
]}

机构：

[1] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA

[2] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada

[3] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada

来源：

NEUROLOGY | 2022年 / 98卷 / 01期

关键词：

D O I：

10.1212/WNL.0000000000013014

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：12 / 13

页数：2

共 7 条

[1] A 30-Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes [J].

Chung, Karen K. ;

Altmann, Daniel ;

Barkhof, Frederik ;

Miszkiel, Katherine ;

Brex, Peter A. ;

O'Riordan, Jonathan ;

Ebner, Michael ;

Prados, Ferran ;

Cardoso, M. Jorge ;

Vercauteren, Tom ;

Ourselin, Sebastien ;

Thompson, Alan ;

Ciccarelli, Olga ;

Chard, Declan T. .

ANNALS OF NEUROLOGY, 2020, 87 (01) :63-74

[2] Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial [J].

Comi, G. ;

Martinelli, V. ;

Rodegher, M. ;

Moiola, L. ;

Bajenaru, O. ;

Carra, A. ;

Elovaara, I. ;

Fazekas, F. ;

Hartung, H. P. ;

Hillert, J. ;

King, J. ;

Komoly, S. ;

Lubetzki, C. ;

Montalban, X. ;

Myhr, K. M. ;

Ravnborg, M. ;

Rieckmann, P. ;

Wynn, D. ;

Young, C. ;

Filippi, M. .

LANCET, 2009, 374 (9700) :1503-1511

[3] Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome [J].

Comi, Giancarlo ;

Martinelli, Vittorio ;

Rodegher, Mariaemma ;

Moiola, Lucia ;

Leocani, Letizia ;

Bajenaru, Ovidiu ;

Carra, Adriana ;

Elovaara, Irina ;

Fazekas, Franz ;

Hartung, Hans-Peter ;

Hillert, Jan ;

King, John ;

Komoly, Samuel ;

Lubetzki, Catherine ;

Montalban, Xavier ;

Myhr, Kjell-Morten ;

Preziosa, Paolo ;

Ravnborg, Mads ;

Rieckmann, Peter ;

Rocca, Maria A. ;

Wynn, Daniel ;

Young, Carolyn ;

Filippi, Massimo .

MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (08) :1074-1083

[4]

Filippi M., 2022, NEUROLOGY, V98, pe1

[5] Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes [J].

Kappos, L. ;

Polman, C. H. ;

Freedman, M. S. ;

Edan, G. ;

Hartung, H. P. ;

Miller, D. H. ;

Montalban, X. ;

Barkhof, F. ;

Bauer, L. ;

Jakobs, P. ;

Pohl, C. ;

Sandbrink, R. .

NEUROLOGY, 2006, 67 (07) :1242-1249

[6] The 11-year long-term follow-up study from the randomized BENEFIT CIS trial [J].

Kappos, Ludwig ;

Edan, Gilles ;

Freedman, Mark S. ;

Montalban, Xavier ;

Hartung, Hans-Peter ;

Hemmer, Bernhard ;

Fox, Edward J. ;

Barkhof, Frederik ;

Schippling, Sven ;

Schulze, Andrea ;

Pleimes, Dirk ;

Pohl, Christoph ;

Sandbrink, Rupert ;

Suarez, Gustavo ;

Wicklein, Eva-Maria .

NEUROLOGY, 2016, 87 (10) :964-964

[7] Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis [J].

McDonald, WI ;

Compston, A ;

Edan, G ;

Goodkin, D ;

Hartung, HP ;

Lublin, FD ;

McFarland, HF ;

Paty, DW ;

Polman, CH ;

Reingold, SC ;

Sandberg-Wollheim, M ;

Sibley, W ;

Thompson, AJ ;

van den Noort, S ;

Weinshenker, BY ;

Wolinsky, JS .

ANNALS OF NEUROLOGY, 2001, 50 (01) :121-127

← 1 →